Diclofenac | Diclofenac-SOLOpharm eye drops 0.1% 5 ml
Special Price
$14.70
Regular Price
$22.00
In stock
SKU
BID689302
Release form
Eye drops, 0.1%.
Eye drops, 0.1%.
Release form
Eye drops, 0.1%.
Packaging
0.5 ml per dropper tube made of low density polyethylene or polypropylene.
For 5 or 10 dropper tubes in a bag of foil film or without it, along with instructions for use in a pack of cardboard.
5 ml in a bottle with a dropper made of low density polyethylene and a cap with the control of the first opening or in a dropper bottle made of high pressure polyethylene complete with a screw cap and a dropper cap.
For 1 bottle, along with instructions for use in a pack of cardboard.
Pharmacological action
Pharmacotherapeutic group:
NSAIDs
ATX:
S.01.BC03 Diclofenac
M.01.AB05 Diclofenac
Pharmacodynamics:
has a potent effect of phenylphenol The mechanism of action is due to the indiscriminate inhibition of the activity of cyclooxygenase 1 and 2, which leads to a suppression of the synthesis of prostaglandins in the focus of inflammation.
When applied topically in the form of eye drops, diclofenac reduces eye inflammation resulting from infection, trauma or surgery, and reduces myosis in surgery, reduces the synthesis of prostaglandins in the moisture of the anterior chamber.
Pharmacokinetics:
The maximum concentration of a substance in the cornea and conjunctiva is reached by 30 minutes after instillation. The drug is rapidly excreted from the body, complete elimination is observed after 6 hours.
The drug penetrates the anterior chamber of the eye into the systemic circulation in therapeutically significant concentrations.
Indications
- Inhibition of myosis during cataract surgery (the drug does not have mydriatic properties and does not replace standard drugs, causing enlargement of the pupil)
- treatment and prevention of inflammatory processes after surgical interventions on the eyeball
- prevention of cystic macular edema after cataract surgery
- treatment of non-infectious conjunctivitis
- treatment and prevention of post-traumatic inflammatory process in case of penetrating like an apple and neopron addition to local antibiotic therapy).
Contraindications
Hypersensitivity to the components of the drug, impaired hematopoiesis of unclear origin, erosive-ulcerative processes in the gastrointestinal tract in the acute stage.
Like other non-steroidal anti-inflammatory drugs (NSAIDs, asthma, drug) acute rhinitis associated with the use of acetylsalicylic acid or other drugs that inhibit the activity of prostaglandinsynthetase. hypersensitivity to acetylsalicylic acid, phenylacetic acid derivatives and other NSAIDs
Intraocular use of the drug during surgical procedures is contraindicated
Precautions:
Epithelial herpetic keratitis (including a history of) of the disease, causing bleeding disorders (including hemophilia, lengthening of bleeding time, tendency to bleeding) bronchial asthma caused by the intake of acetylsalicylic acid in old age.
Use during pregnancy and lactation
The drug is contraindicated in pregnancy because of the possible risk of premature closure of the ductus arteriosus and possible suppression of labor.
Experimental studies have not established a negative effect of diclofenac on pregnancy, embryonic and postnatal development.
When using diclofenac tablets by mouth in nursing mothers at a dose equivalent to 50 ml of the drug Diclofenac-SOLOpharm, 0.1% eye drops, a small trace amount of the drug was revealed in breast milk that did not have an undesirable effect on the baby.
Special instructions
The anti-inflammatory effect of NSAIDs, including diclofenac, may complicate the diagnosis of ocular infections. Patients with an infection of the eye or with a potential risk of its development, the drug should be prescribed along with appropriate antibiotic therapy.
Wearing soft contact lenses is not recommended during treatment with the drug. When using hard lenses, they should be removed before using the drug and put on again 15-20 minutes after instillation.
Pressing the lower lacrimal opening or closing the eyes within 3 minutes after instillation into the conjunctival sac reduces the drug getting into the systemic circulation, which contributes to a more effective local effect of the drug and a decrease in the incidence of systemic side effects.
Do not touch the tip of the pipette to the eye.
Impact on the ability to drive transp. Wed and fur .:
During treatment, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions.
Composition of
1 ml of the preparation contains:
Active ingredient:
Diclofenac sodium - 1.0 mg
Excipients:
Benzalkonium chloride - 0.05 mg
Hydroxypropyl betadex - 20.0 mg
15g
Prdlkp - 4.8 mg
Sodium tetraborate decahydrate (borax) - 0.4 mg
Disodium edetate (Trilon B) - 0.1 mg
Water for injection - up to 1 ml
Description
A clear, colorless or light yellow liquid.
Dosage and Administration
Topically.
To inhibit intraoperative myosis, the drug is instilled into the conjunctival sac for 2 hours at intervals of 30 minutes (4 times) before surgery.
For the prevention of cystic edema of the macula, the drug is instilled 1 drop 3 times a day for 2-3 weeks after surgery.
For the treatment of post-traumatic inflammatory process in case of non-penetrating eyeball injuries, 1 drop is instilled in 4-6 hours.
The duration of treatment is determined by the doctor, depending on the course of the disease and the needs of the patient.
For example, to reduce the severity of pain after surgery in the eyes (after refractive surgery), the drug should be instilled 1-2 drops per hour before surgery, 1-2 drops in the first 15 minutes after surgery and 1 drop every 4-6 hours for 3 days after surgery.
Other indications: 1 drop 3-4 times a day, depending on the severity of the condition. The course of treatment can last from 1 to 2 weeks.
Operating procedure with a dropper tube:
1. Separate one dropper tube, put the rest back into the packaging.
2. Open the dropper tube (after making sure that the solution is in the lower part of the dropper tube, rotate and separate the valve with rotational movements).
3. Instill the required amount of the drug into the eyes.
4. Close the dropper tube with a valve.
An opened dropper tube can be stored for no more than 24 hours, then the dropper tube should be discarded.
Side effects
The adverse events listed below are listed according to frequency of occurrence. The frequency of occurrence is determined as follows: very often (? 1/10), often (? 1/100 and <1/10), infrequently (? 1/1000 and <1/100), rarely (? 1/10000 and <1 / 1000), very rarely (<1/10000, including isolated cases).
Often: temporary mild or moderate eye irritation.
Infrequently: itching in the eyes, conjunctival hyperemia and blurred visual perception (immediately after instillation).
Rarely: spot keratitis or corneal lesions (after repeated use of the drug). In patients at risk of developing corneal lesions, for example, when using glucocorticosteroids or as a result of various diseases (infections, rheumatoid arthritis), with repeated use of the drug in rare cases, it may develop vision-threatening complications: ulcerative or acupressure keratitis, corneal epithelial defects, edema and thinning cornea.
Very rare: shortness of breath and worsening of asthma, eye pain.
Allergic reactions
Rarely: conjunctival hyperemia, allergic conjunctivitis, redness, itching and swelling of the eyelids, urticaria, rash, eczema, erythema, pruritus, hypersensitivity, cough and rhinitis.
Drug Interactions
Instillation of NSAIDs in the conjunctival cavity, including diclofenac, together with glucocorticosteroids (GCS) in patients with severe corneal inflammation can lead to the progression of corneal lesions. Caution should be exercised when using the drug with corticosteroids in patients with severe corneal inflammation.
If necessary, it can be used simultaneously with other eye drops, including those containing corticosteroids. In this case, the interval between instillations should be at least 5 minutes to prevent the active substances from being washed out in subsequent doses.
Overdose
There is no data on the overdose of the drug.
The drug is safe when taken accidentally, as 5 ml of the solution contains 5 mg of diclofenac (3% of the maximum oral daily dose of diclofenac for adults).
Storage Conditions
At a temperature not exceeding 25 РC.
Keep out of the reach and sight of children.
Shelf life
2 years.
After opening the bottle - 1 month.
Do not use after the expiration date.
Deystvuyushtee substance
Diclofenac
Terms and conditions
prescription
dosage form
eye drops
Eye drops, 0.1%.
Packaging
0.5 ml per dropper tube made of low density polyethylene or polypropylene.
For 5 or 10 dropper tubes in a bag of foil film or without it, along with instructions for use in a pack of cardboard.
5 ml in a bottle with a dropper made of low density polyethylene and a cap with the control of the first opening or in a dropper bottle made of high pressure polyethylene complete with a screw cap and a dropper cap.
For 1 bottle, along with instructions for use in a pack of cardboard.
Pharmacological action
Pharmacotherapeutic group:
NSAIDs
ATX:
S.01.BC03 Diclofenac
M.01.AB05 Diclofenac
Pharmacodynamics:
has a potent effect of phenylphenol The mechanism of action is due to the indiscriminate inhibition of the activity of cyclooxygenase 1 and 2, which leads to a suppression of the synthesis of prostaglandins in the focus of inflammation.
When applied topically in the form of eye drops, diclofenac reduces eye inflammation resulting from infection, trauma or surgery, and reduces myosis in surgery, reduces the synthesis of prostaglandins in the moisture of the anterior chamber.
Pharmacokinetics:
The maximum concentration of a substance in the cornea and conjunctiva is reached by 30 minutes after instillation. The drug is rapidly excreted from the body, complete elimination is observed after 6 hours.
The drug penetrates the anterior chamber of the eye into the systemic circulation in therapeutically significant concentrations.
Indications
- Inhibition of myosis during cataract surgery (the drug does not have mydriatic properties and does not replace standard drugs, causing enlargement of the pupil)
- treatment and prevention of inflammatory processes after surgical interventions on the eyeball
- prevention of cystic macular edema after cataract surgery
- treatment of non-infectious conjunctivitis
- treatment and prevention of post-traumatic inflammatory process in case of penetrating like an apple and neopron addition to local antibiotic therapy).
Contraindications
Hypersensitivity to the components of the drug, impaired hematopoiesis of unclear origin, erosive-ulcerative processes in the gastrointestinal tract in the acute stage.
Like other non-steroidal anti-inflammatory drugs (NSAIDs, asthma, drug) acute rhinitis associated with the use of acetylsalicylic acid or other drugs that inhibit the activity of prostaglandinsynthetase. hypersensitivity to acetylsalicylic acid, phenylacetic acid derivatives and other NSAIDs
Intraocular use of the drug during surgical procedures is contraindicated
Precautions:
Epithelial herpetic keratitis (including a history of) of the disease, causing bleeding disorders (including hemophilia, lengthening of bleeding time, tendency to bleeding) bronchial asthma caused by the intake of acetylsalicylic acid in old age.
Use during pregnancy and lactation
The drug is contraindicated in pregnancy because of the possible risk of premature closure of the ductus arteriosus and possible suppression of labor.
Experimental studies have not established a negative effect of diclofenac on pregnancy, embryonic and postnatal development.
When using diclofenac tablets by mouth in nursing mothers at a dose equivalent to 50 ml of the drug Diclofenac-SOLOpharm, 0.1% eye drops, a small trace amount of the drug was revealed in breast milk that did not have an undesirable effect on the baby.
Special instructions
The anti-inflammatory effect of NSAIDs, including diclofenac, may complicate the diagnosis of ocular infections. Patients with an infection of the eye or with a potential risk of its development, the drug should be prescribed along with appropriate antibiotic therapy.
Wearing soft contact lenses is not recommended during treatment with the drug. When using hard lenses, they should be removed before using the drug and put on again 15-20 minutes after instillation.
Pressing the lower lacrimal opening or closing the eyes within 3 minutes after instillation into the conjunctival sac reduces the drug getting into the systemic circulation, which contributes to a more effective local effect of the drug and a decrease in the incidence of systemic side effects.
Do not touch the tip of the pipette to the eye.
Impact on the ability to drive transp. Wed and fur .:
During treatment, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions.
Composition of
1 ml of the preparation contains:
Active ingredient:
Diclofenac sodium - 1.0 mg
Excipients:
Benzalkonium chloride - 0.05 mg
Hydroxypropyl betadex - 20.0 mg
15g
Prdlkp - 4.8 mg
Sodium tetraborate decahydrate (borax) - 0.4 mg
Disodium edetate (Trilon B) - 0.1 mg
Water for injection - up to 1 ml
Description
A clear, colorless or light yellow liquid.
Dosage and Administration
Topically.
To inhibit intraoperative myosis, the drug is instilled into the conjunctival sac for 2 hours at intervals of 30 minutes (4 times) before surgery.
For the prevention of cystic edema of the macula, the drug is instilled 1 drop 3 times a day for 2-3 weeks after surgery.
For the treatment of post-traumatic inflammatory process in case of non-penetrating eyeball injuries, 1 drop is instilled in 4-6 hours.
The duration of treatment is determined by the doctor, depending on the course of the disease and the needs of the patient.
For example, to reduce the severity of pain after surgery in the eyes (after refractive surgery), the drug should be instilled 1-2 drops per hour before surgery, 1-2 drops in the first 15 minutes after surgery and 1 drop every 4-6 hours for 3 days after surgery.
Other indications: 1 drop 3-4 times a day, depending on the severity of the condition. The course of treatment can last from 1 to 2 weeks.
Operating procedure with a dropper tube:
1. Separate one dropper tube, put the rest back into the packaging.
2. Open the dropper tube (after making sure that the solution is in the lower part of the dropper tube, rotate and separate the valve with rotational movements).
3. Instill the required amount of the drug into the eyes.
4. Close the dropper tube with a valve.
An opened dropper tube can be stored for no more than 24 hours, then the dropper tube should be discarded.
Side effects
The adverse events listed below are listed according to frequency of occurrence. The frequency of occurrence is determined as follows: very often (? 1/10), often (? 1/100 and <1/10), infrequently (? 1/1000 and <1/100), rarely (? 1/10000 and <1 / 1000), very rarely (<1/10000, including isolated cases).
Often: temporary mild or moderate eye irritation.
Infrequently: itching in the eyes, conjunctival hyperemia and blurred visual perception (immediately after instillation).
Rarely: spot keratitis or corneal lesions (after repeated use of the drug). In patients at risk of developing corneal lesions, for example, when using glucocorticosteroids or as a result of various diseases (infections, rheumatoid arthritis), with repeated use of the drug in rare cases, it may develop vision-threatening complications: ulcerative or acupressure keratitis, corneal epithelial defects, edema and thinning cornea.
Very rare: shortness of breath and worsening of asthma, eye pain.
Allergic reactions
Rarely: conjunctival hyperemia, allergic conjunctivitis, redness, itching and swelling of the eyelids, urticaria, rash, eczema, erythema, pruritus, hypersensitivity, cough and rhinitis.
Drug Interactions
Instillation of NSAIDs in the conjunctival cavity, including diclofenac, together with glucocorticosteroids (GCS) in patients with severe corneal inflammation can lead to the progression of corneal lesions. Caution should be exercised when using the drug with corticosteroids in patients with severe corneal inflammation.
If necessary, it can be used simultaneously with other eye drops, including those containing corticosteroids. In this case, the interval between instillations should be at least 5 minutes to prevent the active substances from being washed out in subsequent doses.
Overdose
There is no data on the overdose of the drug.
The drug is safe when taken accidentally, as 5 ml of the solution contains 5 mg of diclofenac (3% of the maximum oral daily dose of diclofenac for adults).
Storage Conditions
At a temperature not exceeding 25 РC.
Keep out of the reach and sight of children.
Shelf life
2 years.
After opening the bottle - 1 month.
Do not use after the expiration date.
Deystvuyushtee substance
Diclofenac
Terms and conditions
prescription
dosage form
eye drops
Write Your Own Review